IMRN
IMMURON Ltd/S ADR

5,519
Mkt Cap
$7.19M
Volume
19,493.00
52W High
$2.48
52W Low
$0.8809
PE Ratio
-1.51
IMRN Fundamentals
Price
$0.8809
Prev Close
$0.9133
Open
$0.9133
50D MA
$1.62
Beta
0.66
Avg. Volume
389,014.58
EPS (Annual)
-$0.5852
P/B
0.97
Loading...
Loading...
Immuron Ltd. is a biopharmaceutical company, which focuses on the development and commercialization of a novel class of specifically targeted polyclonal antibodies. It operates through the Hyper-immune Products and Research and Development (R&D) segments. The Hyper-immune Products segment includes income and expenses directly attributable to Travelan and Protectyn activities. The Research and Development segment refers to the group’s R&D projects performed in Australia and United States. The company was founded on January 13, 1994, and is headquartered in Blackburn, Australia.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Immuron Limited - ADR?
What is the 52-week high for Immuron Limited - ADR?
What is the 52-week low for Immuron Limited - ADR?
What is Immuron Limited - ADR stock price today?
What was Immuron Limited - ADR stock price yesterday?
What is the PE ratio of Immuron Limited - ADR?
What is the Price-to-Book ratio of Immuron Limited - ADR?
What is the 50-day moving average of Immuron Limited - ADR?

Latest IMRN News

View

Advertisement|Remove ads.

Advertisement|Remove ads.